nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolcapone—CYP2C9—Thalidomide—leprosy	0.268	0.361	CbGbCtD
Tolcapone—CYP2C9—Rifampicin—leprosy	0.26	0.35	CbGbCtD
Tolcapone—CYP2C9—Dapsone—leprosy	0.214	0.289	CbGbCtD
Tolcapone—Leukaemia—Thalidomide—leprosy	0.00791	0.0307	CcSEcCtD
Tolcapone—Lacrimal structural disorder—Thalidomide—leprosy	0.00725	0.0282	CcSEcCtD
Tolcapone—Meningitis—Thalidomide—leprosy	0.0055	0.0213	CcSEcCtD
Tolcapone—Lacrimal disorder—Thalidomide—leprosy	0.00476	0.0185	CcSEcCtD
Tolcapone—Hernia—Thalidomide—leprosy	0.00454	0.0176	CcSEcCtD
Tolcapone—Cerebral ischaemia—Thalidomide—leprosy	0.00441	0.0171	CcSEcCtD
Tolcapone—Hostility—Thalidomide—leprosy	0.00385	0.0149	CcSEcCtD
Tolcapone—Tooth disorder—Thalidomide—leprosy	0.00328	0.0128	CcSEcCtD
Tolcapone—Seborrhoeic dermatitis—Thalidomide—leprosy	0.00313	0.0121	CcSEcCtD
Tolcapone—Neuralgia—Thalidomide—leprosy	0.00307	0.0119	CcSEcCtD
Tolcapone—Thrombosis—Thalidomide—leprosy	0.00301	0.0117	CcSEcCtD
Tolcapone—Psychotic disorder—Dapsone—leprosy	0.00295	0.0115	CcSEcCtD
Tolcapone—Myocardial ischaemia—Thalidomide—leprosy	0.00265	0.0103	CcSEcCtD
Tolcapone—Influenza—Dapsone—leprosy	0.00261	0.0101	CcSEcCtD
Tolcapone—Apnoea—Thalidomide—leprosy	0.00251	0.00976	CcSEcCtD
Tolcapone—Vasodilation—Thalidomide—leprosy	0.00242	0.00942	CcSEcCtD
Tolcapone—Vasodilation procedure—Thalidomide—leprosy	0.00242	0.00942	CcSEcCtD
Tolcapone—Accidental injury—Thalidomide—leprosy	0.00241	0.00935	CcSEcCtD
Tolcapone—Musculoskeletal stiffness—Thalidomide—leprosy	0.00237	0.00922	CcSEcCtD
Tolcapone—Viral infection—Thalidomide—leprosy	0.00236	0.00916	CcSEcCtD
Tolcapone—Skin discolouration—Thalidomide—leprosy	0.00236	0.00916	CcSEcCtD
Tolcapone—Arthropathy—Thalidomide—leprosy	0.00234	0.0091	CcSEcCtD
Tolcapone—Cellulitis—Thalidomide—leprosy	0.00234	0.0091	CcSEcCtD
Tolcapone—Thinking abnormal—Thalidomide—leprosy	0.00233	0.00904	CcSEcCtD
Tolcapone—Oliguria—Thalidomide—leprosy	0.00231	0.00898	CcSEcCtD
Tolcapone—Herpes simplex—Thalidomide—leprosy	0.00231	0.00898	CcSEcCtD
Tolcapone—Neuropathy peripheral—Dapsone—leprosy	0.00228	0.00886	CcSEcCtD
Tolcapone—Dyskinesia—Thalidomide—leprosy	0.00227	0.00881	CcSEcCtD
Tolcapone—Hypercholesterolaemia—Thalidomide—leprosy	0.00225	0.00875	CcSEcCtD
Tolcapone—Sinusitis—Dapsone—leprosy	0.00218	0.00848	CcSEcCtD
Tolcapone—Gait disturbance—Thalidomide—leprosy	0.00218	0.00848	CcSEcCtD
Tolcapone—Neck pain—Thalidomide—leprosy	0.00216	0.00838	CcSEcCtD
Tolcapone—Pulmonary embolism—Thalidomide—leprosy	0.00213	0.00828	CcSEcCtD
Tolcapone—Hepatocellular injury—Thalidomide—leprosy	0.00213	0.00828	CcSEcCtD
Tolcapone—Pharyngitis—Dapsone—leprosy	0.00207	0.00806	CcSEcCtD
Tolcapone—Colitis—Thalidomide—leprosy	0.00205	0.00795	CcSEcCtD
Tolcapone—Neuropathy—Thalidomide—leprosy	0.002	0.00777	CcSEcCtD
Tolcapone—Tinnitus—Dapsone—leprosy	0.00195	0.00757	CcSEcCtD
Tolcapone—Oesophagitis—Thalidomide—leprosy	0.00195	0.00756	CcSEcCtD
Tolcapone—Pulmonary oedema—Thalidomide—leprosy	0.0019	0.00737	CcSEcCtD
Tolcapone—Hypertonia—Thalidomide—leprosy	0.00187	0.00725	CcSEcCtD
Tolcapone—Hyperkinesia—Thalidomide—leprosy	0.00186	0.00722	CcSEcCtD
Tolcapone—Mental disability—Thalidomide—leprosy	0.00185	0.00718	CcSEcCtD
Tolcapone—Euphoric mood—Thalidomide—leprosy	0.00183	0.00711	CcSEcCtD
Tolcapone—Diabetes mellitus—Thalidomide—leprosy	0.00178	0.00691	CcSEcCtD
Tolcapone—Gastroenteritis—Thalidomide—leprosy	0.00174	0.00678	CcSEcCtD
Tolcapone—Eczema—Thalidomide—leprosy	0.00172	0.00668	CcSEcCtD
Tolcapone—Vision blurred—Dapsone—leprosy	0.00171	0.00666	CcSEcCtD
Tolcapone—Eye pain—Thalidomide—leprosy	0.00171	0.00665	CcSEcCtD
Tolcapone—Injury—Thalidomide—leprosy	0.00168	0.00654	CcSEcCtD
Tolcapone—Libido decreased—Thalidomide—leprosy	0.00167	0.00648	CcSEcCtD
Tolcapone—Amnesia—Thalidomide—leprosy	0.00165	0.00639	CcSEcCtD
Tolcapone—Vertigo—Dapsone—leprosy	0.00163	0.00635	CcSEcCtD
Tolcapone—Atrial fibrillation—Thalidomide—leprosy	0.00163	0.00634	CcSEcCtD
Tolcapone—Arthritis—Thalidomide—leprosy	0.00159	0.00618	CcSEcCtD
Tolcapone—Cough—Dapsone—leprosy	0.00159	0.00617	CcSEcCtD
Tolcapone—Cardiac failure—Thalidomide—leprosy	0.00158	0.00616	CcSEcCtD
Tolcapone—Lethargy—Thalidomide—leprosy	0.00158	0.00613	CcSEcCtD
Tolcapone—Cerebrovascular accident—Thalidomide—leprosy	0.00158	0.00613	CcSEcCtD
Tolcapone—Diplopia—Thalidomide—leprosy	0.00155	0.00601	CcSEcCtD
Tolcapone—Gastrointestinal haemorrhage—Thalidomide—leprosy	0.00155	0.00601	CcSEcCtD
Tolcapone—Osteoarthritis—Thalidomide—leprosy	0.00155	0.00601	CcSEcCtD
Tolcapone—Disturbance in sexual arousal—Thalidomide—leprosy	0.00153	0.00596	CcSEcCtD
Tolcapone—Affect lability—Thalidomide—leprosy	0.00152	0.00591	CcSEcCtD
Tolcapone—Migraine—Thalidomide—leprosy	0.00152	0.00591	CcSEcCtD
Tolcapone—Psychotic disorder—Thalidomide—leprosy	0.00151	0.00587	CcSEcCtD
Tolcapone—Face oedema—Thalidomide—leprosy	0.00149	0.0058	CcSEcCtD
Tolcapone—Cardiac arrest—Thalidomide—leprosy	0.00147	0.00571	CcSEcCtD
Tolcapone—Mood swings—Thalidomide—leprosy	0.00147	0.00569	CcSEcCtD
Tolcapone—Tachycardia—Dapsone—leprosy	0.00145	0.00563	CcSEcCtD
Tolcapone—Dehydration—Thalidomide—leprosy	0.00144	0.00559	CcSEcCtD
Tolcapone—Cramp muscle—Thalidomide—leprosy	0.00139	0.00541	CcSEcCtD
Tolcapone—Alanine aminotransferase increased—Thalidomide—leprosy	0.00136	0.0053	CcSEcCtD
Tolcapone—Influenza—Thalidomide—leprosy	0.00134	0.00519	CcSEcCtD
Tolcapone—Dysphagia—Thalidomide—leprosy	0.00134	0.00519	CcSEcCtD
Tolcapone—Angina pectoris—Thalidomide—leprosy	0.0013	0.00506	CcSEcCtD
Tolcapone—Bronchitis—Thalidomide—leprosy	0.00129	0.00499	CcSEcCtD
Tolcapone—Upper respiratory tract infection—Thalidomide—leprosy	0.00124	0.00483	CcSEcCtD
Tolcapone—Pollakiuria—Thalidomide—leprosy	0.00123	0.0048	CcSEcCtD
Tolcapone—Erectile dysfunction—Thalidomide—leprosy	0.00123	0.00478	CcSEcCtD
Tolcapone—Gastrointestinal pain—Dapsone—leprosy	0.00121	0.00472	CcSEcCtD
Tolcapone—Weight decreased—Thalidomide—leprosy	0.00121	0.0047	CcSEcCtD
Tolcapone—Pneumonia—Thalidomide—leprosy	0.0012	0.00466	CcSEcCtD
Tolcapone—Infestation NOS—Thalidomide—leprosy	0.00119	0.00463	CcSEcCtD
Tolcapone—Infestation—Thalidomide—leprosy	0.00119	0.00463	CcSEcCtD
Tolcapone—Acute coronary syndrome—Thalidomide—leprosy	0.00117	0.00456	CcSEcCtD
Tolcapone—Abdominal pain—Dapsone—leprosy	0.00117	0.00456	CcSEcCtD
Tolcapone—Body temperature increased—Dapsone—leprosy	0.00117	0.00456	CcSEcCtD
Tolcapone—Myocardial infarction—Thalidomide—leprosy	0.00117	0.00454	CcSEcCtD
Tolcapone—Neuropathy peripheral—Thalidomide—leprosy	0.00117	0.00454	CcSEcCtD
Tolcapone—Stomatitis—Thalidomide—leprosy	0.00116	0.00451	CcSEcCtD
Tolcapone—Sweating—Thalidomide—leprosy	0.00114	0.00444	CcSEcCtD
Tolcapone—Haematuria—Thalidomide—leprosy	0.00114	0.00441	CcSEcCtD
Tolcapone—Epistaxis—Thalidomide—leprosy	0.00112	0.00437	CcSEcCtD
Tolcapone—Sinusitis—Thalidomide—leprosy	0.00112	0.00434	CcSEcCtD
Tolcapone—Bradycardia—Thalidomide—leprosy	0.00109	0.00423	CcSEcCtD
Tolcapone—Rhinitis—Thalidomide—leprosy	0.00107	0.00417	CcSEcCtD
Tolcapone—Hypoaesthesia—Thalidomide—leprosy	0.00106	0.00413	CcSEcCtD
Tolcapone—Pharyngitis—Thalidomide—leprosy	0.00106	0.00412	CcSEcCtD
Tolcapone—Urinary tract disorder—Thalidomide—leprosy	0.00106	0.0041	CcSEcCtD
Tolcapone—Oedema peripheral—Thalidomide—leprosy	0.00105	0.00409	CcSEcCtD
Tolcapone—Urethral disorder—Thalidomide—leprosy	0.00105	0.00407	CcSEcCtD
Tolcapone—Erythema multiforme—Thalidomide—leprosy	0.00101	0.00393	CcSEcCtD
Tolcapone—Tinnitus—Thalidomide—leprosy	0.000998	0.00387	CcSEcCtD
Tolcapone—Angiopathy—Thalidomide—leprosy	0.000971	0.00377	CcSEcCtD
Tolcapone—Mediastinal disorder—Thalidomide—leprosy	0.000964	0.00375	CcSEcCtD
Tolcapone—Chills—Thalidomide—leprosy	0.00096	0.00373	CcSEcCtD
Tolcapone—Arrhythmia—Thalidomide—leprosy	0.000956	0.00371	CcSEcCtD
Tolcapone—Alopecia—Thalidomide—leprosy	0.000945	0.00367	CcSEcCtD
Tolcapone—Vomiting—Dapsone—leprosy	0.000944	0.00367	CcSEcCtD
Tolcapone—Mental disorder—Thalidomide—leprosy	0.000937	0.00364	CcSEcCtD
Tolcapone—Headache—Dapsone—leprosy	0.00093	0.00361	CcSEcCtD
Tolcapone—Flatulence—Thalidomide—leprosy	0.000918	0.00356	CcSEcCtD
Tolcapone—Tension—Thalidomide—leprosy	0.000914	0.00355	CcSEcCtD
Tolcapone—Dysgeusia—Thalidomide—leprosy	0.000912	0.00354	CcSEcCtD
Tolcapone—Nervousness—Thalidomide—leprosy	0.000905	0.00351	CcSEcCtD
Tolcapone—Muscle spasms—Thalidomide—leprosy	0.000895	0.00348	CcSEcCtD
Tolcapone—Nausea—Dapsone—leprosy	0.000882	0.00343	CcSEcCtD
Tolcapone—Vision blurred—Thalidomide—leprosy	0.000878	0.00341	CcSEcCtD
Tolcapone—Tremor—Thalidomide—leprosy	0.000873	0.00339	CcSEcCtD
Tolcapone—Ill-defined disorder—Thalidomide—leprosy	0.000864	0.00336	CcSEcCtD
Tolcapone—Anaemia—Thalidomide—leprosy	0.000861	0.00334	CcSEcCtD
Tolcapone—Agitation—Thalidomide—leprosy	0.000856	0.00332	CcSEcCtD
Tolcapone—Malaise—Thalidomide—leprosy	0.00084	0.00326	CcSEcCtD
Tolcapone—Vertigo—Thalidomide—leprosy	0.000837	0.00325	CcSEcCtD
Tolcapone—Syncope—Thalidomide—leprosy	0.000835	0.00324	CcSEcCtD
Tolcapone—Palpitations—Thalidomide—leprosy	0.000823	0.0032	CcSEcCtD
Tolcapone—Loss of consciousness—Thalidomide—leprosy	0.000819	0.00318	CcSEcCtD
Tolcapone—Cough—Thalidomide—leprosy	0.000813	0.00316	CcSEcCtD
Tolcapone—Hypertension—Thalidomide—leprosy	0.000804	0.00312	CcSEcCtD
Tolcapone—Arthralgia—Thalidomide—leprosy	0.000793	0.00308	CcSEcCtD
Tolcapone—Chest pain—Thalidomide—leprosy	0.000793	0.00308	CcSEcCtD
Tolcapone—Myalgia—Thalidomide—leprosy	0.000793	0.00308	CcSEcCtD
Tolcapone—Anxiety—Thalidomide—leprosy	0.00079	0.00307	CcSEcCtD
Tolcapone—Unspecified disorder of skin and subcutaneous tissue—Thalidomide—leprosy	0.000787	0.00306	CcSEcCtD
Tolcapone—Discomfort—Thalidomide—leprosy	0.000783	0.00304	CcSEcCtD
Tolcapone—Dry mouth—Thalidomide—leprosy	0.000775	0.00301	CcSEcCtD
Tolcapone—Confusional state—Thalidomide—leprosy	0.000766	0.00298	CcSEcCtD
Tolcapone—Oedema—Thalidomide—leprosy	0.00076	0.00295	CcSEcCtD
Tolcapone—Infection—Thalidomide—leprosy	0.000755	0.00293	CcSEcCtD
Tolcapone—Shock—Thalidomide—leprosy	0.000748	0.0029	CcSEcCtD
Tolcapone—Nervous system disorder—Thalidomide—leprosy	0.000745	0.0029	CcSEcCtD
Tolcapone—Thrombocytopenia—Thalidomide—leprosy	0.000744	0.00289	CcSEcCtD
Tolcapone—Tachycardia—Thalidomide—leprosy	0.000742	0.00288	CcSEcCtD
Tolcapone—Skin disorder—Thalidomide—leprosy	0.000738	0.00287	CcSEcCtD
Tolcapone—Hyperhidrosis—Thalidomide—leprosy	0.000735	0.00285	CcSEcCtD
Tolcapone—Anorexia—Thalidomide—leprosy	0.000725	0.00281	CcSEcCtD
Tolcapone—Hypotension—Thalidomide—leprosy	0.00071	0.00276	CcSEcCtD
Tolcapone—Musculoskeletal discomfort—Thalidomide—leprosy	0.000693	0.00269	CcSEcCtD
Tolcapone—Paraesthesia—Thalidomide—leprosy	0.000683	0.00265	CcSEcCtD
Tolcapone—Dyspnoea—Thalidomide—leprosy	0.000678	0.00263	CcSEcCtD
Tolcapone—Somnolence—Thalidomide—leprosy	0.000676	0.00262	CcSEcCtD
Tolcapone—Dyspepsia—Thalidomide—leprosy	0.000669	0.0026	CcSEcCtD
Tolcapone—Decreased appetite—Thalidomide—leprosy	0.000661	0.00257	CcSEcCtD
Tolcapone—Gastrointestinal disorder—Thalidomide—leprosy	0.000656	0.00255	CcSEcCtD
Tolcapone—Fatigue—Thalidomide—leprosy	0.000655	0.00255	CcSEcCtD
Tolcapone—Constipation—Thalidomide—leprosy	0.00065	0.00252	CcSEcCtD
Tolcapone—Pain—Thalidomide—leprosy	0.00065	0.00252	CcSEcCtD
Tolcapone—Feeling abnormal—Thalidomide—leprosy	0.000626	0.00243	CcSEcCtD
Tolcapone—Gastrointestinal pain—Thalidomide—leprosy	0.000622	0.00241	CcSEcCtD
Tolcapone—Urticaria—Thalidomide—leprosy	0.000604	0.00235	CcSEcCtD
Tolcapone—Abdominal pain—Thalidomide—leprosy	0.000601	0.00233	CcSEcCtD
Tolcapone—Body temperature increased—Thalidomide—leprosy	0.000601	0.00233	CcSEcCtD
Tolcapone—Hypersensitivity—Thalidomide—leprosy	0.00056	0.00218	CcSEcCtD
Tolcapone—Asthenia—Thalidomide—leprosy	0.000545	0.00212	CcSEcCtD
Tolcapone—Pruritus—Thalidomide—leprosy	0.000538	0.00209	CcSEcCtD
Tolcapone—Diarrhoea—Thalidomide—leprosy	0.00052	0.00202	CcSEcCtD
Tolcapone—Dizziness—Thalidomide—leprosy	0.000503	0.00195	CcSEcCtD
Tolcapone—Vomiting—Thalidomide—leprosy	0.000483	0.00188	CcSEcCtD
Tolcapone—Rash—Thalidomide—leprosy	0.000479	0.00186	CcSEcCtD
Tolcapone—Dermatitis—Thalidomide—leprosy	0.000479	0.00186	CcSEcCtD
Tolcapone—Headache—Thalidomide—leprosy	0.000476	0.00185	CcSEcCtD
Tolcapone—Nausea—Thalidomide—leprosy	0.000452	0.00175	CcSEcCtD
